The invention relates to immunotherapeutic compounds and to methods for stimulating an
immune response in a subject individual at risk for developing cancer, diagnosed with a …

Disclosed are immunotherapeutic compositions and the concurrent use of combinations of
such compositions for the improved induction of therapeutic immune responses and/or for …

Disclosed herein are methods and compositions related to combination therapy for cancer.
More specifically, several treatment modalities are used in combination to induce an …

This application is a continuation-in-part of US applica tion Ser. No. 09/535,212, filed Mar.
27, 2000, now US Pat. No. 6,565,852, issued May 20, 2003, which is a continua tion-in-part …

0004 2. Description of the Related Art 0005 The American Cancer Society has estimated
that over one million people get cancer each year, and that approximately one out of every …

This document provides methods and materials related to treating cancer. For example, this
document pro vides methods and materials for using an anti-chronic inflam mation treatment …

OPGTXAUDXWCGFI-UHFFFAOYSA-N [1-[[6-[[3-(3-dodecanoyloxytetradecanoylamino)-6-
(hydroxymethyl)-5-phosphonooxy-4-(3-tetradecanoyloxytetradecanoyloxy) oxan-2-yl] …

Provided are methods of reducing the size of a tumor or inhibiting the growth of cancer cells
in an individual or inhibiting the development of metastatic cancer by administering an …

BACKGROUND 0003) While great progress has been made in diagnosing cancer, there has
been a lag in the development of new treat ments to target tumors. Cancer immunotherapy …

The present invention relates to methods and compositions for the treatment of diseases,
including cancer, infectious diseases and autoimmune diseases. The present invention also …